Medical Device Network

Olympus launches second VC fund with $150m commitment

Olympus Corporation has committed $150m to a new VC fund, aiming to deploy the capital to promising medtech startups in the ...
Medical Device Network

Philips doubles down on image-guided therapy with SpectraWAVE acquisition

Philips has inked a deal to acquire enhanced vascular imaging (EVI) product developer SpectraWAVE, expanding the Dutch ...
Medical Device Network

Vaxxas gains Australia’s TGA licence to manufacture HD microarray patch

Vaxxas has received a manufacturing licence from Australia’s Therapeutic Goods Administration (TGA) for its high-density ...
Medical Device Network

FDA approves P&F’s transcatheter bicaval valve system trial

The FDA has granted approval for P&F USA to begin the TRICAV II pivotal trial of the TricValve transcatheter bicaval valve ...
Medical Device Network

Subsense secures $10m to advance BCI R&D efforts

US-based Subsense has raised $10m, bringing the brain-computer interface (BCI) developer’s total funding to $27m since it ...
Medical Device Network

Vesalio secures FDA clearance for enVast clot retriever

The Food and Drug Administration (FDA) has granted 510(k) clearance for Vesalio’s enVast clot retriever, paving the way for ...
Medical Device Network

Guardant Health and Trial Library to expand access to US cancer trials

Guardant Health and AI technology firm Trial Library have formed a strategic partnership aimed at improving access to cancer ...
Medical Device Network

FDA clears Flow Neuroscience’s at-home depression treatment in US first

The US Food and Drug Administration (FDA) has cleared Flow Neuroscience’s at-home, non-drug depression treatment, making it ...
Medical Device Network

FDA greenlights Lumos Labs’ digital ADHD therapeutic

Lumos Labs has gained US Food and Drug Administration (FDA) clearance for LumosityRx, a prescription digital therapeutic (PDT) that aims to improve attention span in adult patients with attention ...
Medical Device Network

Impulse Dynamics raises $158m to advance clinical and technology pipelines

Impulse Dynamics has secured over $158m in funding aimed at supporting its commercialisation efforts and progressing its ...
Medical Device Network

First patient treated in Nitinotes’ trial of EndoZip system for ESG

Nitinotes has commenced its US investigational device exemption (IDE) Endoscopic Automated Sleeve Evaluation (EASE) Clinical ...
Medical Device Network

FDA clears HeartBeam’s at-home arrhythmia assessment tool

HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis ...